Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
affiliate, BioPharmaceutical, bond, call, Chatham, dialogue, EFSF, Fasonut, filler, FlowsCondensed, French, gene, IncomeCondensed, individually, Laboratoire, milestone, parenteral, penetration, refined, rehearing, rejection, SheetsCondensed, shutdown, void
Removed:
AWP, behalf, consented, designed, determine, dismissal, dozen, eligible, endoscopy, executing, health, IGIV, improperly, incremental, indemnity, inflated, introduced, large, Las, manipulated, manufactured, manufacturer, Medicaid, Medicare, Nevada, nineteen, offering, originated, penalty, permit, prepaid, propofol, qui, receive, recourse, reentry, refund, replace, resolved, reused, seek, service, Servicing, sought, Spectrum, tam, terminate, Teva, transmission, trial, unused, USA, weakening, wholesale
Filing tables
Filing exhibits
Related press release
BAX similar filings
Filing view
External links
EXHIBIT 15
August 2, 2012
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Commissioners:
We are aware that our report dated August 2, 2012 on our review of interim financial information of Baxter International Inc. (the “company”) for the three- and six-month periods ended June 30, 2012 and 2011 and included in the company’s quarterly report on Form 10-Q for the quarter ended June 30, 2012 is incorporated by reference in its Registration Statements on Form S-8 (Nos. 333-43563, 333-47019, 333-88257, 333-48906, 333-62820, 333-102140, 333-104420, 333-104421, 333-105032, 333-143063, 333-174400 and 333-174401) and on Form S-3 (No. 333-123811).
Very truly yours, |
/s/ PricewaterhouseCoopers LLP |
PricewaterhouseCoopers LLP |
Chicago, Illinois |